Turning the Corner: Patient-Focused Drug Development Meeting for Hyperhidrosis
Charleston, S.C., Dec. 5, 2017: The International Hyperhidrosis Society hosted a landmark Patient-Focused Drug Development (PFDD) Meeting for Hyperhidrosis in Washington, DC on November 13, 2017.
This meeting provided hyperhidrosis patients’ with a platform to make their voices — and needs — heard by treatment developers, healthcare providers, and regulatory professionals from the U.S. Food and Drug Administration (FDA). And now OPEN COMMENT PERIOD NEEDS YOUR INPUT.